MARIAN SCHINI, MD, PhD: Kyowa Kirin International: Honorarium Recipient (); Medical Research Council Versus Arthritis Centre for Integrated Research into Musculoskeletal Ageing: Funding for fellowship (); Osteoporosis 2000 Charity: Funding for fellowship (); Roche Diagnostics: Grant Recipient (); UCB: Honorarium Recipient ()
This session characterizes the clinical problem of post-denosumab rebound, provides a comprehensive update on human studies examining the use of bisphosphonates following denosumab and explores mechanistic insights from preclinical studies that will be critical in the design of definitive human trials.
.jpg)
.jpg)
